Trial Profile

The effect of dose titration of LY2189265 in overweight and obese patients with type 2 diabetes mellitus

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dulaglutide (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms EGO

Most Recent Events

24 Sep 2010 Results from an exploratory analysis investigating the differences in outcomes between Hispanics and Caucasians were reported at the 46th Annual Meeting of the European Association for the Study of Diabetes.
16 Dec 2009 Actual patient number from 262 to 266 as reported by ClinicalTrials.gov.
18 Oct 2009 Results presented at the 20th World Diabetes Congres (WDC).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com